Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Environ Biol ; 2012 Jul; 33(4): 713-716
Article in English | IMSEAR | ID: sea-148417

ABSTRACT

An incubation experiment was conducted to study the changes that occur in organic carbon content, phosphorous and potassium availability and other soil properties with ingestion of soil mixed with rubber leaf litter and cow dung by five earthworm species viz. Pontoscolex corethrurus, Drawida assamensis, Drawida papillifer papillifer, Eutyphoeus comillahnus and Metaphire houlleti of rubber plantation in Tripura (India). Due to earthworm activity organic C (1.56-1.63%) and available P (14.71-27.60 mg 100 g-1) and K (43.50-49.0 mg 100 g-1) content of the soil increased significantly (p<0.05) in most of the earthworm species studied. M. houlleti and D. papillifer papillifer had the highest P (27.60 mg 100 g-1) and K (49.0 mg 100 g-1) mobilization capacity, respectively. Earthworms, irrespective of the species, increased the pH (7.05-7.17) and electrical conductivity (663-1383 µS cm-1) of the soil significantly (p<0.05).

2.
J Indian Med Assoc ; 2004 Sep; 102(9): 488, 490, 492 passim
Article in English | IMSEAR | ID: sea-106019

ABSTRACT

Gatifloxacin is a broad spectrum fluoroquinolone that offers enhanced Gram-positive activity and anaerobic coverage to other fluoroquinolones. The pharmacokinetic parameters (Cmax, AUCo-t, tmax) of this drug have been evaluated to compare the single dose (400mg) bioavailability of gatifloxacin with the reference formulation. High performance liquid chromatography (HPLC) coupled with U-V detector set at 290 nm has been used to determine plasma concentration of 12 human volunteers as per DCGI (Drug Controller General of India) guidelines. The method has been validated over a linear range of 0.25 to 8 microg/ml from plasma. The minimum quantifiable concentration has been set at 0.25 microg/ml (% CV < 10%). The pharmacokinetic parameters are: Cmax = 4.366 +/- 0.44 microg/ml at tmax = 1.83 +/- 0.44 hour, AUCO0-t = 25.26 +/- 2.91 microg hour/ml, AUCo-inf = 33.68 +/- 4.31 microg hour/ml, Kel = 0.094 +/- 0.024/hour and t1/2 = 8.0 +/- 1.92 hour.


Subject(s)
Administration, Oral , Adult , Area Under Curve , Biological Availability , Calibration , Chromatography, High Pressure Liquid , Cross-Over Studies , Fluoroquinolones/administration & dosage , Humans
3.
J Indian Med Assoc ; 2004 Jan; 102(1): 26, 28, 30
Article in English | IMSEAR | ID: sea-98688

ABSTRACT

The newly developed proton pump inhibitor rabeprazole sodium is expected to have beneficial effects in the treatment of peptic ulcer. The pharmacokinetic parameters (C(max), AUC(o-t), t(max)) of this drug have been evaluated to compare the single dose (20 mg) bioavailability of rabeprazole sodium with the standard reference. High performance liquid chromatography (HPLC) coupled with UV detector set at 280 nm has been used to determine plasma concentration of 12 human volunteers as per Drugs Controller General of India (DCGI) guidelines. The method has been validated over a linear range of 20-480 ng/ml from plasma. The minimum quantifiable concentration was set at 10 ng/ml [co-efficient of variance (CV) < 10%]. By comparing AUC(o-t) the relative bioavailability of test preparation has been found to be 100.88% of that of reference preparation.


Subject(s)
2-Pyridinylmethylsulfinylbenzimidazoles , Adenosine Triphosphatases/antagonists & inhibitors , Anti-Ulcer Agents/blood , Benzimidazoles/blood , Cross-Over Studies , Dose-Response Relationship, Drug , Humans , Male , Omeprazole/analogs & derivatives , Proton-Translocating ATPases/antagonists & inhibitors , Therapeutic Equivalency
4.
J Indian Med Assoc ; 2003 Aug; 101(8): 486-8
Article in English | IMSEAR | ID: sea-103759

ABSTRACT

A convenient, sensitive and simple method for the determination of rofecoxib in human plasma is presented. The analytical technique is based on reversed phase high performance liquid chromatography coupled with UV detector (Knauer, Germany) set at 272 nm. The retention time of rofecoxib after recovery from plasma, was 8.9 minutes. The method has been validated over a linear range of 50-450 ng/ml from plasma. After validation the method was used to study the pharmacokinetic profile of rofecoxib in 6 healthy volunteers as per DCGI guidelines after administration of a single oral dose (50 mg). The extraction efficiency from plasma varied from 93.95-99.58%. The minimum quantifiable concentration was set at 50 ng/ml (% CV < 10%). The pharmacokinetic parameters were Cmax = 318.58 +/- 30.65 ng/ml at tmax = 2.66 +/- 0.25 hours, AUC0-t = 4007.88 +/- 438.32 ng hour/ml, AUC0-yen = 5454.66 +/- 822.29 ng hour/ml, Kel = 0.0433 +/- 0.0067/hour, and t1/2 = 16.36 +/- 2.89 hours.


Subject(s)
Area Under Curve , Chromatography, High Pressure Liquid , Cyclooxygenase Inhibitors/blood , Humans , Lactones/blood , Reference Standards , Reproducibility of Results , Sulfones
6.
Article in English | IMSEAR | ID: sea-87244

ABSTRACT

The present study was designed to study the clinical behaviour of a recent epidemic of typhoid fever in West Bengal. Of 46 cases studied, 67% (31) had chloramphenicol resistant typhoid fever. The chloramphenicol-resistant cases were comparatively severe in nature with higher complication and mortality rates. Salmonella typhi resistant to chloramphenicol were also resistant to ampicillin, cloxaxillin and cotrimoxazole. Strains of Salmonella typhi sensitive to chloramphenicol retained their sensitivity to these other antimicrobials.


Subject(s)
Adult , Chloramphenicol/therapeutic use , Chloramphenicol Resistance , Disease Outbreaks , Female , Humans , India/epidemiology , Male , Microbial Sensitivity Tests , Salmonella typhi/drug effects , Typhoid Fever/drug therapy
7.
Indian J Exp Biol ; 1989 Aug; 27(8): 695-8
Article in English | IMSEAR | ID: sea-55980

ABSTRACT

Salivary lactate dehydrogenase (LDH), peroxidase (Px) and leucine aminopeptidase (LAP) activities were scanned in both normally ovulating and anovulating women during entire menstrual cycle. In ovulating women, all the three enzymes exhibited significant increase in the activity on or before the onset of ovulation which was monitored by the shift of the basal body temperature (BBT) as well as the ferning pattern of the cervical mucus. The peak maximum at the midcycle was several times higher than the previous day value in all the six normal women. In anovulatory women, no such remarkable change in the enzyme activities was found throughout the cycle. Salivary LDH and LAP showed peak at the midcycle and at the same time required short time for assay, so the present results are strongly suggestive that the determination of salivary enzyme content may be a convenient method for detecting the day of ovulation.


Subject(s)
Female , Humans , L-Lactate Dehydrogenase/biosynthesis , Leucyl Aminopeptidase/biosynthesis , Menstrual Cycle/physiology , Peroxidases/biosynthesis , Salivary Glands/enzymology
8.
Article in English | IMSEAR | ID: sea-21569

ABSTRACT

The crystallization phenomenon of human cervical mucus was investigated with the help of scanning electron microscope. Changes in the conformation of crystals and ferning patterns were studied on different days of the menstrual cycle in both normally ovulating women and those using oral contraceptives. No crystalline structure was found on day 5 in both categories of women, whereas square crystals were observed on day 21 in normal woman. Nature and type of ferning pattern changes seen from days 11 to 14 in normal women were not seen during this period in women who were on oral contraception, instead a thick, viscous mucus was found during the entire period of the cycle.


Subject(s)
Adult , Cervix Mucus/cytology , Contraceptives, Oral, Combined/pharmacology , Contraceptives, Oral, Hormonal/pharmacology , Crystallization , Female , Humans , Menstrual Cycle , Microscopy, Electron, Scanning
SELECTION OF CITATIONS
SEARCH DETAIL